BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 6, Issue 1
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Pediatrics
ISSN
2219-2808
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study
©The Author(s) 2017.
World J Clin Pediatr. Feb 8, 2017; 6(1): 34-39
Published online Feb 8, 2017. doi: 10.5409/wjcp.v6.i1.34
Figure 1
Full Size Figure Download Figure
Figure 1 Length of time on continuous albuterol based on admission pediatric asthma severity score illustration of the difference in length of time on continuous albuterol among the three severity groups. The mild compromise group received continuous albuterol for 10 h (IQR: 5-15), moderate compromise group for 15 h (IQR: 7.75-23.75), and the severe compromise group for 21.5 h (IQR: 11.5-27.5) (P = 0.001).
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.